A new five-year biotech plan has been released by the Chinese government, revealing ambitious goals such as achieving five blockbuster medicines on the global markets in that time.
Electra Therapeutics has exceeded its initial fundraising plans as it becomes the 26th biotech to debut publicly this year and outlines pivotal development plans for its monoclonal antibody ipsoprubart.
The National Association of Tax Professionals is asking Senate Finance Committee leaders to prod their colleagues to take up the wide-ranging legislation.
The Defense Department plans to shift from its traditional use of cost accounting to the more widely prevalent U.S. GAAP to make it easier to do business with companies.